- As per market grapevine, during weak market phases investors look for policy support and stability. Some market participants believe measures such as lowering STT, STCG and LTCG could help attract stronger FII participation, especially when foreign investors are already facing currency depreciation pressures.
- As per market veterans, Nifty has corrected nearly 15% from its peak. Wealth is usually created during such sharp corrections when fear is high and valuations become attractive. Many investors say they would have invested during events like COVID-19, but when uncertainty actually appears, most hesitate. Markets reward patience and conviction during volatility. The recent war-led correction has created negative sentiment but also opened attractive entry points, again highlighting that a diversified portfolio across asset classes delivers over time.
- Capital Protection Lesson: A recent options trade in Sensex illustrates the danger of leverage. A trader shorted the 71,800 CE at Rs.101 expecting the market to stay weak. However, as the market reversed sharply, the option surged to around Rs.1607, turning a potential Rs.1 lakh gain into a loss of nearly Rs.15 lakh for a 1000-quantity position. Such episodes highlight that leverage and naked option selling without strict stop-losses can destroy capital quickly. Markets often punish ego-driven trades and risk management remains the most important rule for survival. For smaller traders, especially those with capital below Rs.5 cr., aggressive F&O strategies—particularly option writing—can be extremely risky. Protecting capital should always come before chasing profits.
- Key Results Calendar: (a) April 6 – Ikoma Technologies, Vuenow Infratech, Sterling Powergensys, (b) April 8 – M. Breweries, (c) April 9 – Anand Rathi Wealth, TCS, (d) April 13 – ICICI Prudential AMC, (e) April 14 – ICICI Prudential Life Insurance, (f) April 15 – ICICI Lombard General Insurance, HDB Financial Services, (g) April 16 – HDFC AMC, Angel One, HCL Technologies, (h) April 18 – HDFC Bank, ICICI Bank, (i) April 20 – Mphasis, (j) April 21 – Infosys, Nestle India, (k) April 22 – Amal, CIE Automotive India, (l) April 23 – Tata Capital, UTI AMC, Mahindra Logistics, (m) April 24 – Atul, (n)April 25 – IDFC First Bank, India Cements, SBFC Finance (o) April 27 – UltraTech Cement, Nippon Life India AMC (p) April 28 – Mahindra Lifespace Developers, KFin Technologies, (q) April 29 – Navin Fluorine International, (r) April 30 – Dr. Lal PathLabs, L.G. Balakrishnan & Bros. Stock-specific volatility is likely around results announcements.
- Marksans Pharma has received US FDA approval for Benzonatate Capsules USP, a non-narcotic antitussive used to suppress cough. Just keep on track.
